We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00111449
Recruitment Status : Completed
First Posted : May 23, 2005
Last Update Posted : May 15, 2013
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):